000 | 01965 a2200577 4500 | ||
---|---|---|---|
005 | 20250515203222.0 | ||
264 | 0 | _c20100322 | |
008 | 201003s 0 0 eng d | ||
022 | _a0394-6320 | ||
024 | 7 |
_a10.1177/039463200902200426 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDe Martino, L | |
245 | 0 | 0 |
_aVerbena officinalis essential oil and its component citral as apoptotic-inducing agent in chronic lymphocytic leukemia. _h[electronic resource] |
260 |
_bInternational journal of immunopathology and pharmacology _c |
||
300 |
_a1097-104 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAcyclic Monoterpenes |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xchemistry |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Situ Hybridization, Fluorescence |
650 | 0 | 4 | _aKaryotyping |
650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xenzymology |
650 | 0 | 4 |
_aLymphocytes _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMonoterpenes _xisolation & purification |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aOils, Volatile _xchemistry |
650 | 0 | 4 | _aPlant Components, Aerial |
650 | 0 | 4 |
_aPlant Oils _xchemistry |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
650 | 0 | 4 |
_aVerbena _xchemistry |
700 | 1 | _aD'Arena, G | |
700 | 1 | _aMinervini, M M | |
700 | 1 | _aDeaglio, S | |
700 | 1 | _aFusco, B M | |
700 | 1 | _aCascavilla, N | |
700 | 1 | _aDe Feo, V | |
773 | 0 |
_tInternational journal of immunopathology and pharmacology _gvol. 22 _gno. 4 _gp. 1097-104 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/039463200902200426 _zAvailable from publisher's website |
999 |
_c19452076 _d19452076 |